Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population

Affiliations

• ¹ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
• ² Neurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium.
• ³ Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
• ⁴ Neuromuscular Reference Centre, Department of Neurology, Antwerp University Hospital, Antwerp, Belgium.
• ⁵ Neurology Clinic, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia.
• ⁶ Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
• ⁷ Iranian Center of Neurological Research, Tehran University of Medical Sciences, Tehran, Iran.
• ⁸ Department of Neurosciences 'Rita Levi Montalcini', University of Turin, Turin, Italy.
• ⁹ Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
• ¹⁰ Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
• ¹¹ The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
• ¹² King's College Hospital, London, UK.
• ¹³ Northern Molecular Genetics Service, Biomedicine East Wing, Newcastle upon Tyne, UK.
• ¹⁴ Muscle Immunoanalysis Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
• ¹⁵ Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
• ¹⁶ Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
• ¹⁷ John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK volker.straub@ncl.ac.uk.